NCT01428492 2018-08-08
PKB115125
Novartis
Phase 1 Completed
Clinical Trials
3 trialsNCT01476137 2017-11-13
A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers
GlaxoSmithKline
Phase 1 Completed
NCT01445587 2012-03-26
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
GlaxoSmithKline
Phase 2 Withdrawn